This report studies Nanomedicine in the Global market, especially in North America, China, Europe, Southeast Asia, Japan, and India, with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.
Nanomedicine is a branch of medicine that uses nanotechnology for the prevention and treatment of diseases. Nanometer-sized particles offer better drug loading efficiency and increased absorbability. Moreover, nanomedicine can increase the time period in which a drug remains active in the body. These benefits are expected to boost the growth of the global nanomedicine market over the forecast period.
Technological advancement in nanotechnology is expected to propel the growth of the global nanomedicine market over the forecast period. For instance, in February 2020, researchers from the University of Waterloo integrated 3D printing and nanomedicine to develop an intra-vaginal ring that can provide precise doses of medication to halt HIV infection at the site of transmission. Moreover, increasing demand for nanomedicine for the treatment of cancer is also expected to aid in the growth of the market. Nanocarriers increase the cytotoxicity of the transported drug upon short incubation times. Moreover, nanotechnology increases the efficacy of natural biomaterials through the use of nanocarriers formulated with gold, silver, cadmium sulfide, and titanium dioxide polymeric nanoparticles.
Although nanomedicines have been successfully introduced in clinical practice, there are several regulatory hurdles that are expected to hinder the growth of the global nanomedicine market. Some nanomedicines or follow-on versions (nanosimiliars) available in the market lack therapeutic equivalence. This is attributed to inappropriate authorization pathways. Moreover, the complexity of nanomedicine is a major challenge to assess the quality, safety, and efficacy of products.
R&D in cell-based nanoparticle delivery systems for targeted cancer therapy is expected to offer lucrative growth opportunities for players in the global nanomedicine market. For instance, in August 2019, researchers from Huazhong University of Science and Technology, China, reported the development of biocompatible tumor-cell-exocytosed exosome-biomimetic porous silicon nanoparticles as a drug carrier for targeted cancer chemotherapy.
The use of nanobots for the treatment of chronic diseases is an emerging trend in the market. Nanobots can be equipped with wireless transmitters or planted into a patient’s nervous system to monitor pulse and brainwave activities.
Players in the market are focused on the development and launch of novel nanopharmaceuticals to expand their product portfolio. For instance, in February 2020, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced that CNM-Au8 Gold Nanocrystals demonstrated preclinical efficacy for remyelination in multiple sclerosis
Key Takeaways:
- Technological advancement in nanotechnology to augment the growth of the global nanomedicine market over the forecast period
- R&D in cell-based nanoparticles delivery systems for targeted cancer therapy is expected to offer lucrative growth opportunities for players in the global nanomedicine market
- Major players operating in the global nanomedicine market include GE Healthcare, Johnson & Johnson, Mallinckrodt plc., Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A
This report focuses on top manufacturers in the global market, with production, price, revenue, and market share for each manufacturer, covering
✒ GE Healthcare
✒ Johnson & Johnson
✒ Mallinckrodt plc
✒ Merck & Co. Inc.
✒ Nanosphere Inc.
✒ Pfizer Inc.
✒ Sigma-Tau Pharmaceuticals Inc.
✒ Smith & Nephew PLC
✒ Stryker Corp
✒ Teva Pharmaceutical Industries Ltd.
✒ UCB (Union chimique belge) S.A
On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into
✒ Regenerative Medicine
✒ In-vitro & In-vivo Diagnostics
✒ Vaccines
✒ Drug Delivery
By Application, the market can be split into
✒ Clinical Cardiology
✒ Urology
✒ Genetics
✒ Orthopedics
✒ Ophthalmology
By Regions, this report covers (we can add the regions/countries as you want)
✒ North America
✒ China
✒ Europe
✒ Southeast Asia
✒ Japan
✒ India
[**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.]
Table of Contents
Global Nanomedicine Market Professional Survey Report 2019
1 Industry Overview of Nanomedicine
1.1 Definition and Specifications of Nanomedicine
1.1.1 Definition of Nanomedicine
1.1.2 Specifications of Nanomedicine
1.2 Classification of Nanomedicine
1.2.1 Regenerative Medicine
1.2.2 In-vitro & In-vivo Diagnostics
1.2.3 Vaccines
1.2.4 Drug Delivery
1.3 Applications of Nanomedicine
1.3.1 Clinical Cardiology
1.3.2 Urology
1.3.3 Genetics
1.3.4 Orthopedics
1.3.5 Ophthalmology
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Nanomedicine
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nanomedicine
2.3 Manufacturing Process Analysis of Nanomedicine
2.4 Industry Chain Structure of Nanomedicine
3 Technical Data and Manufacturing Plants Analysis of Nanomedicine
3.1 Capacity and Commercial Production Date of Global Nanomedicine Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Nanomedicine Major Manufacturers in 2018
3.3 R&D Status and Technology Source of Global Nanomedicine Major Manufacturers in 2018
3.4 Raw Materials Sources Analysis of Global Nanomedicine Major Manufacturers in 2018
4 Global Nanomedicine Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Nanomedicine Capacity and Growth Rate Analysis
4.2.2 2018 Nanomedicine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Nanomedicine Sales and Growth Rate Analysis
4.3.2 2018 Nanomedicine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Nanomedicine Sales Price
4.4.2 2018 Nanomedicine Sales Price Analysis (Company Segment)
5 Nanomedicine Regional Market Analysis
5.1 North America Nanomedicine Market Analysis
5.1.1 North America Nanomedicine Market Overview
5.1.2 North America 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Nanomedicine Sales Price Analysis
5.1.4 North America 2018 Nanomedicine Market Share Analysis
5.2 China Nanomedicine Market Analysis
5.2.1 China Nanomedicine Market Overview
5.2.2 China 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Nanomedicine Sales Price Analysis
5.2.4 China 2018 Nanomedicine Market Share Analysis
5.3 Europe Nanomedicine Market Analysis
5.3.1 Europe Nanomedicine Market Overview
5.3.2 Europe 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Nanomedicine Sales Price Analysis
5.3.4 Europe 2018 Nanomedicine Market Share Analysis
5.4 Southeast Asia Nanomedicine Market Analysis
5.4.1 Southeast Asia Nanomedicine Market Overview
5.4.2 Southeast Asia 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Nanomedicine Sales Price Analysis
5.4.4 Southeast Asia 2018 Nanomedicine Market Share Analysis
5.5 Japan Nanomedicine Market Analysis
5.5.1 Japan Nanomedicine Market Overview
5.5.2 Japan 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Nanomedicine Sales Price Analysis
5.5.4 Japan 2018 Nanomedicine Market Share Analysis
5.6 India Nanomedicine Market Analysis
5.6.1 India Nanomedicine Market Overview
5.6.2 India 2014-2019E Nanomedicine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Nanomedicine Sales Price Analysis
5.6.4 India 2018 Nanomedicine Market Share Analysis
6 Global 2014-2019E Nanomedicine Segment Market Analysis (by Type)
6.1 Global 2014-2019E Nanomedicine Sales by Type
6.2 Different Types of Nanomedicine Product Interview Price Analysis
6.3 Different Types of Nanomedicine Product Driving Factors Analysis
6.3.1 Regenerative Medicine of Nanomedicine Growth Driving Factor Analysis
6.3.2 In-vitro & In-vivo Diagnostics of Nanomedicine Growth Driving Factor Analysis
6.3.3 Vaccines of Nanomedicine Growth Driving Factor Analysis
6.3.4 Drug Delivery of Nanomedicine Growth Driving Factor Analysis
7 Global 2014-2019E Nanomedicine Segment Market Analysis (by Application)
7.1 Global 2014-2019E Nanomedicine Consumption by Application
7.2 Different Application of Nanomedicine Product Interview Price Analysis
7.3 Different Application of Nanomedicine Product Driving Factors Analysis
7.3.1 Clinical Cardiology of Nanomedicine Growth Driving Factor Analysis
7.3.2 Urology of Nanomedicine Growth Driving Factor Analysis
7.3.3 Genetics of Nanomedicine Growth Driving Factor Analysis
7.3.4 Orthopedics of Nanomedicine Growth Driving Factor Analysis
7.3.5 Ophthalmology of Nanomedicine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Nanomedicine
8.1 GE Healthcare
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 GE Healthcare 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GE Healthcare 2018 Nanomedicine Business Region Distribution Analysis
8.2 Johnson & Johnson
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Johnson & Johnson 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Johnson & Johnson 2018 Nanomedicine Business Region Distribution Analysis
8.3 Mallinckrodt plc
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Mallinckrodt plc 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Mallinckrodt plc 2018 Nanomedicine Business Region Distribution Analysis
8.4 Merck & Co. Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Merck & Co. Inc. 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Merck & Co. Inc. 2018 Nanomedicine Business Region Distribution Analysis
8.5 Nanosphere Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Nanosphere Inc. 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Nanosphere Inc. 2018 Nanomedicine Business Region Distribution Analysis
8.6 Pfizer Inc.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer Inc. 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer Inc. 2018 Nanomedicine Business Region Distribution Analysis
8.7 Sigma-Tau Pharmaceuticals Inc.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Sigma-Tau Pharmaceuticals Inc. 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sigma-Tau Pharmaceuticals Inc. 2018 Nanomedicine Business Region Distribution Analysis
8.8 Smith & Nephew PLC
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Smith & Nephew PLC 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Smith & Nephew PLC 2018 Nanomedicine Business Region Distribution Analysis
8.9 Stryker Corp
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Stryker Corp 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Stryker Corp 2018 Nanomedicine Business Region Distribution Analysis
8.10 Teva Pharmaceutical Industries Ltd.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Teva Pharmaceutical Industries Ltd. 2018 Nanomedicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Teva Pharmaceutical Industries Ltd. 2018 Nanomedicine Business Region Distribution Analysis
8.11 UCB (Union chimique belge) S.A
9 Development Trend of Analysis of Nanomedicine Market
9.1 Global Nanomedicine Market Trend Analysis
9.1.1 Global 2019-2022 Nanomedicine Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Nanomedicine Sales Price Forecast
9.2 Nanomedicine Regional Market Trend
9.2.1 North America 2019-2022 Nanomedicine Consumption Forecast
9.2.2 China 2019-2022 Nanomedicine Consumption Forecast
9.2.3 Europe 2019-2022 Nanomedicine Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Nanomedicine Consumption Forecast
9.2.5 Japan 2019-2022 Nanomedicine Consumption Forecast
9.2.6 India 2019-2022 Nanomedicine Consumption Forecast
9.3 Nanomedicine Market Trend (Product Type)
9.4 Nanomedicine Market Trend (Application)
10 Nanomedicine Marketing Type Analysis
10.1 Nanomedicine Regional Marketing Type Analysis
10.2 Nanomedicine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Nanomedicine by Region
10.4 Nanomedicine Supply Chain Analysis
11 Consumers Analysis of Nanomedicine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Nanomedicine Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source
Request Discount 
Inquire Before Buy
